U.S. doctors reconsider Pfizer's Paxlovid for lower-risk COVID patients

Use of Pfizer Inc's COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency warned that symptoms can recur after people complete a course of the drug...

Factors that are Reshaping Pharma Contract Manufacturing

Post the outburst of COVID-19 pandemic, the pharmaceutical sector across the globe sought contract manufacturing in a big way.

Top 5 Technologies that support digital manufacturing of Biologics

The biologics market comprises sales of biologics and related services by entities which include sole traders, partnerships & organizations

Trivitron develops kit for detection of Monkeypox virus

Medical devices firm Trivitron Healthcare on Friday said it has developed a real-time PCR-based kit for the detection of Monkeypox virus, even as researchers are currently underway to understand the epidemiology, sources of spread, and the patterns..

Torrent Pharma acquires 4 Brands from Dr.Reddy's laboratories

Ahmedabad based Torrent Pharmaceuticals today announced that it has entered into an agreement with Dr. Reddy's Laboratories Ltd. to acquire four of its brands "Styptovit-E", "Finast", "Finast-T", and "Dynapress"...

Medley Pharma likely to be sold in Rs 5,000 crore

Medley Pharma, the privately held Mumbai-based firm, is on the block. Drug majors like Cipla, Dr Reddy’s, KKR-backed JB Chemicals, and Torrent, along with marquee private equity investors Advent, Carlyle and Blackstone are seen as potential buyers...

Roche develops monkeypox PCR tests

Swiss pharmaceutical giant Roche said Wednesday it had come up with PCR tests that can detect monkeypox, as the virus spreads outside endemic countries...

Moderna testing potential monkeypox vaccines

Moderna Inc is testing potential vaccines against monkeypox in pre-clinical trials as the disease spreads in the United States and Europe...

Pfizer to trade all its patented drugs at nonprofit price in low-income countries

Pfizer Inc will make all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance available at a not-for-profit price to 45 of the world's low-income countries, the drugmaker said on Wednesday....

Pfizer presents ELEVATE pivotal result demonstrating etrasimod's potentially best-n-class profile in ulcerative colitis

Pfizer Inc. announced detailed results from two pivotal studies that make up the ELEVATE UC phase 3 registrational programme evaluating etrasimod, a once-daily, oral, selective sphingosine 1-phosphate (S1P) receptor modulator for the treatment...

© 2025 India Pharma Outlook. All Rights Reserved.